| Trial ID: | L0192 |
| Source ID: | NCT00506506
|
| Associated Drug: |
N-Acetylcysteine
|
| Title: |
Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: N-acetylcysteine|DRUG: Placebo
|
| Outcome Measures: |
Primary: 24 hour creatinine clearance, estimated glomerular filtration rate (eGFR), proteinuria and cystatin C |
|
| Sponsor/Collaborators: |
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Collaborators: The Physicians' Services Incorporated Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
|
| Start Date: |
2007-10
|
| Completion Date: |
2008-10
|
| Results First Posted: |
|
| Last Update Posted: |
2009-04-15
|
| Locations: |
London Health Sciences Centre, London, Ontario, N6A 5W9, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00506506
|
